Navigation Links
Researchers at Meharry Medical College Find Green Tea Extract Showing Promise for Treatment of Uterine Fibroids,
Date:1/23/2010

Human trials soon to begin which could lead to new treatments for millions of women suffering from fibroid tumors

Nashville, TN (Vocus) January 22, 2010 -- Researchers at Meharry Medical College have discovered that an extract of green tea could be used as a treatment for uterine fibroids, a disease that affects forty percent of reproductive age women.

An article published this week in the American Journal of Obstetrics and Gynecology, by Meharry’s Director of Clinical Research, Dr. Ayman Al-Hendy and his team of investigators, stated that an extract of green tea has the ability to kill human leiomyoma cells in tissue cultures and can eradicate fibroid lesions in animal models.

Al-Hendy said if the treatment is found to be effective in humans it can change the lives of millions of women who are currently faced with hysterectomy as their only treatment option.

“If we can prove this compound is effective, millions of women can start self treatment and self management,” he said.

The symptoms of uterine fibroids are often debilitating and include excessive vaginal bleeding, anemia, fatigue and lack of energy. According to Al-Hendy, women who suffer from uterine fibroids may lose time from work, have higher medical expenses and often need advanced medical treatment in order to become pregnant – all things that cause both emotional and economic hardship for families.

Al-Hendy and his team have conducted extensive research on the treatment of fibroid tumors and are dedicated to finding a cure for this disease which disproportionately affects African-American women who are four times more likely to be affected than women from other ethnic groups.

Researchers are in the process of recruiting participants for human trials that will begin soon.

The research will be conducted under the umbrella of the Meharry Clinical and Translational Research Center (MeTRC). In 2009, Meharry was awarded a $21.4 million grant from the National Center for Research Resources (NCRR) to establish MeTRC which will help accelerate the process of turning laboratory discoveries into actual cures and treatments used by patients.

MeTRC is a “center without walls” comprised of the Center for AIDS Health Disparities Research, the Center for Women’s Health Research and the Participant and Clinical Interactions Resource. Al-Hendy and Dr. James E.K. Hildreth serve as the principal investigators of this institutional grant.

About Meharry Medical College: Meharry Medical College is the nation’s largest private, independent, historically black academic health center dedicated solely to educating minority and other health professionals. True to its heritage, it is a United Methodist Church affiliated institution. The College is particularly well known for its uniquely nurturing, highly effective educational programs; emerging preeminence in health disparities research; culturally sensitive, evidence-based health services; and significant contribution to the diversity of the nation’s health professions workforce. Diverse Issues in Higher Education’s ranking of institutions annually lists Meharry as a leading national educator of African Americans with M.D. and D.D.S. degrees, and Ph.D. degrees in the biomedical sciences. Visit www.mmc.edu to learn more.

Contact:
Janet M. Caldwell: 615.500.0632
Cynthia Yeldell: 615.327.6986 or 615.280.0319

###

Read the full story at http://www.prweb.com/releases/Meharry_Medical_College/Uterine_Fibroid_Research/prweb3499084.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Researchers welcome new multiple sclerosis drug
2. Barrow researchers receive more than $2 million in NIH grants for nicotine studies
3. Researchers discover method to objectively identify PTSD
4. Researchers find a treatment for deadly brain tumor
5. Researchers find new insights into inherited retinal disease
6. Pitt researchers raise concern over frequency of surveillance colonoscopy
7. Stress triggers tumor formation, Yale researchers find
8. Johns Hopkins researchers say vaccine appears to mop up leukemia cells Gleevec leaves behind
9. St. Johns wort not helpful treatment for irritable bowel syndrome, Mayo Clinic researchers say
10. Young hunters most likely to be injured using tree stands, say UAB researchers
11. Researchers find clues to why some continue to eat when full
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers at Meharry Medical College Find Green Tea Extract Showing Promise for Treatment of Uterine Fibroids,
(Date:5/25/2016)... ... May 25, 2016 , ... ... seen a significant spike in their clients' employee participation for their wellness initiatives. ... screening by implementing a high-deductible health plan with outcome-based deductible incentives. As a ...
(Date:5/25/2016)... Jersey (PRWEB) , ... May 25, 2016 , ... ... technology firm will be selling the device branded as Stern’s Real Time Monitoring ... geared to bedbugs to the hotel and motel industry, colleges for use in dormitories, ...
(Date:5/24/2016)... ... May 24, 2016 , ... PhishLine, the best-in-class, enterprise ... company as Vice President of Sales. Cifolelli’s primary responsibilities include management of ... the rapidly expanding field of organizational social engineering. , “We are delighted ...
(Date:5/24/2016)... ... ... Jericho Project has named LaToya Williams-Belfort to the position of Chief Development and Communications ... the nationally-acclaimed nonprofit, working closely with CEO Tori Lyon and the Board of Directors ... , “LaToya Williams-Belfort is joining Jericho at an exciting time of growth and ...
(Date:5/24/2016)... , ... May 24, 2016 , ... How to Write ... Raleigh, NC, http://www.fdanews.com/humanerrordrugdevice , Human error is known to be the major ... human error will ever be totally eliminated, many human performance problems can be prevented. ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
(Date:5/24/2016)... , May 24, 2016 ... Markt gebracht, die es Ärzten erlaubt, ihre Expertise ... behandeln: MDLinking kombiniert Live Streaming mit einer Instant-Messaging-Funktion ... zu kommunizieren. Mediziner in Europa, Afrika, Asien und ... bereits für die Plattform registriert. Information ...
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und demonstriert ... in ‚ausgezeichneter plus guter , ...    ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... heute neue positive Daten von der MORA-Studie der ...
Breaking Medicine Technology: